A 4550 New Jersey General Assembly · 2026-2027 Regular Session

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

This bill requires health insurance plans in New Jersey to cover the prescription and purchase of buprenorphine and buprenorphine/naloxone for pain treatment without using step therapy or fail-first protocols. It applies to various types of insurance contracts, including hospital service, medical service, and health service corporation plans, as well as individual and group health insurance policies. The law ensures that people with these insurance plans can access these medications directly without first trying other treatments or meeting additional requirements.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 10, 2026 Last action Mar 10, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Mar 10, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Carol Murphy
Carol Murphy
DDemocratic
NJ
7